A bioRxiv preprint published October 14, 2026 reports recovery of human-scale porcine kidneys after storage at -150 °C for up to one year. The kidneys were approximately 100 times larger than previously nanowarmed organs. A new cryoprotectant formulation, multithermic perfusion, controlled cooling with annealing, and staged electromagnetic volumetric nanowarming enabled ice-free vitrification, rapid rewarming, and avoidance of cracking. After rewarming, kidneys showed vascular, metabolic, and excretory function during normothermic perfusion, produced urine immediately after transplantation, and exhibited limited histological injury.
The result addresses two central barriers to civilisation-scale biobanking: organ size and storage duration. Functional recovery approaching static cold-storage outcomes, and comparable in several measures to kidneys exposed only to cryoprotectant, indicates that vitrification, one-year cryogenic storage, and nanowarming added minimal detectable functional injury in this model. It does not yet demonstrate multi-decade stability, human-organ safety, autonomous lunar operation, or preservation of complex tissues such as brains and embryos.
The Ark team should track peer-reviewed validation, longer storage intervals, post-transplant survival, cryoprotectant toxicity, nanowarming equipment reliability, and scaling beyond kidneys. A preservation demonstrator should be evaluated for redundant -150 °C storage, low-power monitoring, radiation shielding, sealed perfusion cartridges, and recovery using locally maintainable electromagnetic hardware; priority should go to tissues and organs whose loss would be irreversible for a small lunar population.